SIA Submissions to Government
2016
During 2016, SIA provided written submissions to the following reviews on behalf of its members
- NISA - Engagement and Impact Assessment Consultation Paper
- R&D Tax review
- National Infrastructure Roadmap
If you would like a copy of these submissions please email adminsia@scienceindustry.com.au
AUGUST 2009
DIISR call for submissions on how the Commonwealth Commercialisation Institute (CCI) should operate.
Major issues addressed:
- Principles and Governance
- Bridging the "Innovation Gap"
- Importance of Proof of Concept (PoC)
- Role of PoC as a metric to measure research output
- The role for a Small Business Innovation Research (SBIR) funding regime in Australia
- National Research Priorities
JULY 2009
Victorian Government review of the attractiveness of manufacturing here in Victoria.
Major issues addressed:
- explore the necessary criteria used by businesses to transfer offshore manufacturing to Victoria; and
- identify and report on the factors which influence businesses in determining whether to manufacture in Australia or overseas including the consideration of:
- The retention of intellectual property rights;
- Maintaining consistent quality standards in line with both federal and state laws;
- Probity matters;
- Assistance and incentives provided by government; and
- The impact that the global deterioration in economic conditions in recent months will have on future decisions regarding manufacturing locations.
FEBRUARY 2009
National Trade Measurement LegislationProposal to Amend the National Measurement Regulations 1999.
Feedback to Consultation Paper
APRIL 2008
DIISR review of the National Innovation System (NIS).
Major issues addressed:
- Principles and Governance
- Bridging the "Innovation Gap"
- Importance of Proof of Concept (PoC)
- Role of PoC as a metric to measure research output
- "Open Source" access to IP generated by Publicly Funded Research Agencies (PFRAs)
- The role for a Small Business Innovation Research (SBIR) funding regime in Australia
- National Research Priorities
APRIL 2008
DFAT review of Export Policies.
Major issues addressed:
- General Issues
- Structural & Supply Side Factors
- Trade Development Programs & Services
- Support for SMEs, and
- Financing Exports
AUGUST 2006
DITR Industry Statement - Global Integration
Major issues covered:
- Global integration;
- International competitiveness;
- Innovation; and
- Investment
FEBRUARY 2006
NSW Regulation Review
DECEMBER 2005
Regulation Taskforce.
In-vitro Diagnostics Framework - Class 1 inclusions
- Ozone Protection - Contained Refrigerant Gases licensing fees
- NICNAS - Research and Development and Analysis chemical reporting
- Material Safety Data Sheet preparation costs
DECEMBER 2005
National Model Regulations - National Working Group for Drug Precursors
- Need for uniformity of state and territory legislation supporting the SIA and PACIA Drug Precursor Code of Practice
DEST - National Collaborative Research Infrastructure Strategy, Strategic Roadmap
DEST - Research Quality Framework
- Potential negative impact on Commercialisation of preferred model of the RQF
NOVEMBER 2005
Regulation Taskforce
- The Science Industry Action Agenda Regulatory Reform
- Industry Impost of Regulations in Australia
- Changing Dynamics of International Reforms
- Role of the Council of Australian Governments
- Case Studies & Action Imperatives
APRIL 2005
House of Representatives Standing Committee on Legal and Constitutional Affairs - Harmonisation of Trade and Commerce Regulation
House of Representatives Standing Committee on Science and Innovation - Inquiry into Pathways to Technological Innovation - Marketing our Innovations
DFTA - Australia / China Free Trade Agreement
DECEMBER 2004
Parliament of Victoria, Education and Training Committee - Submission on science/maths education and skills shortages
Drug Precursor Code
The production, supply and use of illicit amphetamines is, regrettably, an substantial problem within the Australian society. As community awareness grows, so do the efforts to stem the flow of these illicit substances.
Health, education and law enforcement agencies are directing significant coordinated resources to not only reduce the amount of illicit amphetamines, but also to deal with the effect they have on users.
Adherence to the law and guidelines by the science and chemical industries, complimented by voluntary co-operation with initiatives of police and health agencies, will enhance resources for protecting the health and safety of the community.
Science Industry Australia are active members of the National Working Group on the Diversion of Precursor Chemicals.
To view or download a copy of the Code of Practice for Supply Diversion into Illicit Drug Manufacture please click here.